Rhythm Pharmaceuticals Inc (RYTM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Sales | 51,298 | 48,502 | 32,704 | 41,830 | 33,251 |
| Cost of Goods | 5,499 | 5,543 | 3,648 | 3,786 | 3,828 |
| Gross Profit | 45,799 | 42,959 | 29,056 | 38,044 | 29,423 |
| Operating Expenses | 98,951 | 88,798 | 76,708 | 80,083 | 74,136 |
| Operating Income | -52,653 | -45,296 | -47,004 | -41,253 | -43,885 |
| Interest Expense | 4,742 | 5,817 | 5,409 | 6,003 | 5,242 |
| Other Income | 4,602 | 4,818 | 2,995 | 3,839 | 5,142 |
| Pre-tax Income | -52,793 | -46,295 | -49,418 | -43,417 | -43,985 |
| Income Tax | 111 | 337 | 80 | -89 | -344 |
| Net Income Continuous | -52,904 | -46,632 | -49,498 | -43,328 | -43,641 |
| Net Income | $-52,904 | $-46,632 | $-49,498 | $-43,328 | $-43,641 |
| EPS Basic Total Ops | -0.82 | -0.75 | -0.81 | -0.71 | -0.73 |
| EPS Basic Continuous Ops | -0.80 | -0.73 | -0.78 | -0.68 | -0.71 |
| EPS Diluted Total Ops | -0.82 | -0.75 | -0.81 | -0.71 | -0.73 |
| EPS Diluted Continuous Ops | -0.80 | -0.73 | -0.78 | -0.68 | -0.71 |
| EPS Diluted Before Non-Recurring Items | -0.82 | -0.75 | -0.81 | -0.72 | -0.73 |
| EBITDA(a) | $-52,349 | $-44,917 | $-46,621 | $-40,870 | $-43,500 |